Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History IMVT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics IMVT

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Immunovant Inc

IMVT
Current price
17.91 USD -0.37 USD (-2.02%)
Last closed 18.28 USD
ISIN US45258J1025
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 3 127 141 376 USD
Yield for 12 month -36.04 %
1Y
3Y
5Y
10Y
15Y
IMVT
21.11.2021 - 28.11.2021

Immunovant, Inc., a clinical-stage immunology company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1402 for graves' disease, rheumatoid arthritis, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, cutaneous lupus erythematosus disease, and sjögren's disease; and batoclimab for graves' disease and thyroid eye disease. The company has a license agreement with HanAll Biopharma Co., Ltd. for the rights of intellectual property relating to IMVT-1402 and batoclimab. Immunovant, Inc. was founded in 2018 and is based in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd. Address: 320 West 37th Street, New York, NY, United States, 10018

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

43.38 USD

P/E Ratio

Dividend Yield

Financials IMVT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures IMVT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

Last Year

Current Quarter

+160 000 USD

Last Quarter

Current Year

Last Year

-231 000 USD

Current Quarter

+80 000 USD

Last Quarter

EBITDA -437 775 008 USD
Operating Margin TTM
Price to Earnings
Return On Assets TTM -37.97 %
PEG Ratio
Return On Equity TTM -62.46 %
Wall Street Target Price 43.38 USD
Revenue TTM
Book Value 4.16 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -2.73 USD
Diluted Eps TTM -2.73 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin

Stock Valuation IMVT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -14.12
Price Book MRQ 4.50

Technical Indicators IMVT

For 52 Weeks

12.72 USD 34.47 USD
50 Day MA 15.55 USD
Shares Short Prior Month 19 918 341
200 Day MA 21.52 USD
Short Ratio 15.71
Shares Short 20 443 952
Short Percent 22.49 %